(1)
Paller, A.; Cork, M. .; Hong, C.- ho .; Soong, W.; Schneider, S.; Lo, H.; Pedersen, L. R. M. .; Vacko, E. .; Wollenberg, A. Laboratory Parameters in Adolescent Patients Aged 12–17 With Moderate-to-Severe Atopic Dermatitis Treated With Tralokinumab Up to Week 52: Results from the Phase 3 ECZTRA 6 Trial. J of Skin 2024, 8, s323.